Results 251 to 260 of about 4,560,972 (405)

Efficient and model‐agnostic parameter estimation under privacy‐preserving post‐randomization data

open access: yesCanadian Journal of Statistics, EarlyView.
Abstract Balancing data privacy with public access is critical for sensitive datasets. However, even after de‐identification, the data are still vulnerable to, for example, inference attacks (by matching some keywords with external datasets). Statistical disclosure control (SDC) methods offer additional protection, and the post‐randomization method ...
Qinglong Tian, Jiwei Zhao
wiley   +1 more source

Synthesis, Antimycobacterial Activity and Computational Insight of novel 1,4‐Benzoxazin‐2‐one Derivatives as Promising Candidates Against Multidrug‐Resistant M. tuberculosis

open access: yesChemMedChem, Accepted Article.
To search for new antitubercular agents, we have designed, synthesized, and evaluated a series of 1,4‐benzoxazinone‐based compounds. These molecules showed potent antimycobacterial activity, with MIC between 2 and 8 μg/mL. This interesting profile included activity against several drug‐resistant strains and minimal cytotoxicity against mammalian Vero ...
Daniele Zampieri   +6 more
wiley   +1 more source

Design and evaluation of a Women in American Medical Informatics Association (AMIA) leadership program. [PDF]

open access: yesJ Am Med Inform Assoc, 2021
Grando A   +6 more
europepmc   +1 more source

Improved C5‐Amide Bioisosteres for Human Neuraminidase 1 Inhibitors Based on 2‐Deoxy‐2,3‐Didehydro‐N‐Acetyl Neuraminic Acid

open access: yesChemMedChem, EarlyView.
This article describes the development of improved NEU1 inhibitors based on the 2‐deoxy‐2,3‐didehydro‐N‐acetyl neuraminic acid scaffold. A series of candidate inhibitors are designed containing bioisosteres of the C5‐amide group and evaluated for activity against NEU1‐4 enzymes.
Mostafa Radwan   +2 more
wiley   +1 more source

Medical informatics

open access: yesپژوهان, 2013
Shahla Nournejad
doaj  

Home - About - Disclaimer - Privacy